NOT AFFECTED

Foster’s Pharmacy would like to announce that there is a voluntary recall on all Metformin ER tablets. This recall stems from a recent series of tests that revealed unacceptably high levels of N-nitrosodimethylamine, a probable human carcinogen, in several lots of metformin extended-release products.

As a result of the advisory, HSA’s manufacturer, Apotex Corp has recalled Metformin Hydrochloride 500mg Extended Release Tablets. The recall does not include the regular release Metformin 500mg tablets.

For those patients taking Metformin ER, please contact your physician or pharmacist to facilitate the relevant adjustment.

Should you have any questions or concerns, please do not hesitate to reach out by email ([email protected]) or by phone (345-945-3663).

END